
|Videos|April 18, 2017
Managing Effective Specialty Drug Distribution
Author(s)Lauren Santye, Assistant Editor
Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses optimal support for distribution of specialty therapies.
Advertisement
Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses optimal support for distribution of specialty therapies.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Early Recognition and Routine Discussion: Improving Outcomes in Tardive Dyskinesia
2
The Menin Inhibitor Landscape in AML: Setting the Clinical Stage
3
Why Stanford, Harvard, and Yale Are Betting on Psychedelics
4
Targeting CSF1R in TGCT: Evaluating the Evidence and Empowering Pharmacist-Led Care
5










































































































